<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Bartonella quintana infections: Clinical features, diagnosis, and treatment</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Bartonella quintana infections: Clinical features, diagnosis, and treatment</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Bartonella quintana infections: Clinical features, diagnosis, and treatment</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David H Spach, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephen B Calderwood, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keri K Hall, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 21, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span><em>Bartonella quintana</em> is a species of <em>Bartonella</em>, which historically caused "trench fever" and more recently has been associated with a variety of infections including bacteremia, endocarditis, and bacillary angiomatosis.</p><p>The clinical features, diagnosis, and treatment of <em>B. quintana</em> infection will be reviewed here. Endocarditis due to <em>Bartonella</em> spp, <em>Bartonella</em> infection in people with HIV (eg, bacillary angiomatosis, peliosis hepatis), and bartonella infections caused by species other than <em>B. quintana</em> are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2145.html" rel="external">"Endocarditis caused by Bartonella"</a> and  <a class="medical medical_review" href="/z/d/html/5512.html" rel="external">"Bartonella infections in people with HIV"</a> and  <a class="medical medical_review" href="/z/d/html/5532.html" rel="external">"Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease"</a> and  <a class="medical medical_review" href="/z/d/html/5530.html" rel="external">"Treatment of cat scratch disease"</a> and  <a class="medical medical_review" href="/z/d/html/5516.html" rel="external">"South American bartonellosis: Oroya fever and verruga peruana"</a>.)</p><p class="headingAnchor" id="H216867004"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span><em>B. quintana</em> is a small, fastidious, gram-negative rod formerly known as <em>Rochalimaea quintana</em>, <em>Rickettsia quintana</em>, <em>Rickettsia weigli</em>, <em>Rickettsia volhynia</em>, and <em>Rickettsia pediculi</em> [<a href="#rid1">1</a>].</p><p>Other <em>Bartonella </em>spp that cause human disease include <em>B. henselae </em>and <em>B. bacilliformis. </em>Further details regarding those species and the general microbiology of <em>Bartonella </em>spp are found separately. (See  <a class="medical medical_review" href="/z/d/html/5519.html" rel="external">"Basic biology of Bartonella species"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H3131580552"><span class="h2">History</span><span class="headingEndMark"> — </span>During World War I, <em>B. quintana</em> infection emerged as a major source of morbidity among soldiers and was commonly referred to as trench fever. More than a million soldiers developed trench fever, and military physicians established the War Office Trench Fever Investigation Commission [<a href="#rid2">2,3</a>]. This group identified the causative organism and determined that the human body louse was the vector for the infectious pathogen. During World War II, a significant, but less extensive, trench fever epidemic occurred. </p><p>Subsequently, endemic and sporadic outbreaks of trench fever were reported in the middle part of the 20<sup>th</sup> century in multiple regions of the world, including Ethiopia (1946), Poland (1949), Mexico (1954), USSR (1960), and Tunisia (1961) [<a href="#rid4">4</a>].</p><p class="headingAnchor" id="H4258996779"><span class="h2">Geography</span><span class="headingEndMark"> — </span><em>B. quintana </em>has a worldwide distribution, although clinically significant infections are uncommon. Since the 1990s, cases have been sporadically reported in the United States, Europe, Russia, Brazil, and East Africa [<a href="#rid5">5-13</a>]. </p><p class="headingAnchor" id="H2059280032"><span class="h2">Risk factors</span><span class="headingEndMark"> — </span>Contemporary <em>B. quintana</em> infections occur in situations that foster very close contact of humans, particularly environments with poor hygienic conditions where lice infestations can occur. Outbreaks have been reported in individuals experiencing homelessness, living in refugee camps, and incarcerated in crowded jails or prisons [<a href="#rid5">5-7,11,14-24</a>]. Those with HIV, alcohol use disorder, or injection drug use may be particularly prone to infection [<a href="#rid5">5,7,11,15,19,25,26</a>]. </p><p>Determining the overall prevalence of <em>B. quintana </em>infection in at-risk populations is challenging, in part because persons with infection may be asymptomatic and may not seek health care. Serologic antibody studies of impoverished or homeless populations in the United States and France have found that 8 to 53 percent had prior <em>B</em>. <em>quintana</em> infection compared with 0 to 2 percent of healthy blood donors; studies from other locales have found similar results [<a href="#rid6">6,15-19,26</a>]. Blood culture screening studies have found rates of <em>B. quintana </em>bacteremia ranging from 5 to 14 percent among populations of individuals who are homeless, compared with 0 percent of sex- and age-matched controls [<a href="#rid6">6,18</a>].</p><p class="headingAnchor" id="H3"><span class="h2">Transmission</span><span class="headingEndMark"> — </span>Humans are the main host for <em>B</em>. <em>quintana</em>, and the primary route of spread is via exposure to infected lice [<a href="#rid1">1,3,6,11,13,20-22,24,26</a>]. Available data suggest the body louse (<em>P. humanus</em> var <em>corporis</em>) is the predominant vector, although the head louse (<em>Pediculus humanus</em> var <em>capitis</em>) and pubic louse (<em>P. humanus</em> var <em>pubis</em>) can also potentially transmit <em>B. quintana</em>. </p><p>Lice become carriers of the organism by feeding on an infected human or other animal reservoir. Noninfected humans acquire the organism from inoculation of infected louse feces into abraded skin or conjunctiva. An infected louse can excrete millions of <em>B. quintana</em> organisms in its feces per day [<a href="#rid24">24,27</a>]. The bite of the louse does not appear to transmit infection to humans [<a href="#rid3">3,24,28</a>]. </p><p>Besides lice, other potential vectors have been proposed, but data supporting their role in transmission to humans are scarce. For example, cats are not natural hosts for <em>B. quintana</em>, but the organism has been isolated from cat fleas and cat dental pulp; rare cases of infection have been reported following exposure to cats, including cat scratches [<a href="#rid1">1,5,29-31</a>]. In a study from 1939, ticks were reported to harbor the organism after feeding on infected humans [<a href="#rid32">32</a>]. Bed bugs (<em>Cimex</em> <em>lectularius</em>) can acquire <em>B</em>. <em>quintana</em> and release the bacteria in their feces [<a href="#rid33">33</a>].</p><p>Although humans are thought to be the main host for <em>B</em>. <em>quintana</em>, nonhuman primates, specifically macaques, also serve as natural hosts for the organism [<a href="#rid34">34</a>]. Data suggest that <em>B. quintana </em>disease in humans may have originated zoonotically from spillover of subsets of macaque <em>B. quintana </em>strains into human populations.</p><p class="headingAnchor" id="H4"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Contemporary infections caused by <em>B. quintana</em> encompass a number of distinct syndromes [<a href="#rid35">35</a>].</p><p class="headingAnchor" id="H3557258541"><span class="h2">Incubation period</span><span class="headingEndMark"> — </span>The incubation period ranges from 5 to 20 days, based on controlled studies of human volunteers inoculated with infected louse feces [<a href="#rid36">36</a>]. In the original reports from World War I, the incubation period was 7 to 8 days [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H5"><span class="h2">Febrile illness</span><span class="headingEndMark"> — </span>Febrile illness can have variable presentations, ranging from a mild self-limited influenza-like illness to chronic, debilitating disease [<a href="#rid2">2,32,36</a>]. Typical symptoms and signs include malaise, fever, headache, dizziness, bone pain (particularly of the shins), splenomegaly, nausea, vomiting, and, in some instances, a macular truncal rash [<a href="#rid3">3</a>]. </p><p>Three major fever patterns have been identified [<a href="#rid2">2,36</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Three to five recurrent febrile episodes, each lasting four to five days, with asymptomatic intervals of four to five days between each episode. This is classic "trench fever" and was the most frequent form of illness during the early half of the twentieth century, including World War I. It was termed "quintan fever" or "pentan fever" because of the recurring five-day attacks. Experts today presume that those patients with classic trench fever had bacteremia, but this is unproven because patients during those times did not get blood cultures. In modern times, this form of illness (ie, classic trench fever) is uncommon.</p><p class="bulletIndent1"><span class="glyph">●</span>A single febrile episode lasting four to five days.</p><p class="bulletIndent1"><span class="glyph">●</span>Persistent fever lasting two to six weeks.</p><p></p><p class="headingAnchor" id="H869031490"><span class="h2">Chronic bacteremia</span><span class="headingEndMark"> — </span>After resolution of febrile events, prolonged asymptomatic bacteremia can persist for weeks to months. Patients may have persistently positive blood cultures, or bacteremia may be intermittent. In some outbreak situations, positive cultures are found in individuals who have no recollection of prior febrile or systemic illness [<a href="#rid5">5,6,25,29,37</a>].</p><p class="headingAnchor" id="H2154400806"><span class="h2">Endocarditis</span><span class="headingEndMark"> — </span>Data suggest that 20 to 43 percent of patients with <em>B. quintana </em>bacteremia have endocarditis [<a href="#rid5">5,6,25</a>]. The organism is also a significant cause of culture-negative endocarditis, causing up to 15 percent of culture-negative endocarditis cases in some series [<a href="#rid9">9,10,38</a>]. <em>B. quintana</em> is a more frequent cause of endocarditis than<em> B. henselae</em> and may be associated with more frequent systemic emboli<em> </em>[<a href="#rid7">7,8,38,39</a>]<em>. </em></p><p>Clinical manifestations of bartonella endocarditis match those of bacteremia (eg, malaise, fever). In addition, a heart murmur, weight loss, or signs of systemic emboli (eg, stroke, skin findings) may be present. A detailed description of bartonella endocarditis is found elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2145.html" rel="external">"Endocarditis caused by Bartonella"</a>.)</p><p class="headingAnchor" id="H362713374"><span class="h2">Infections in people with HIV</span><span class="headingEndMark"> — </span>In individuals with advanced HIV (eg, CD4 &lt;100 cells/microL), <em>B. quintana</em> infections were first described in the early 1990s, particularly among those experiencing homelessness or crowded living situations where lice infestations can occur [<a href="#rid12">12,40</a>]. </p><p>Patients with any stage of HIV can present with the various forms of <em>B. quintana </em>illness (eg, febrile illness, chronic bacteremia, endocarditis) [<a href="#rid11">11,19</a>]. In addition, patients with advanced HIV can have unique presentations (ie, bacillary angiomatosis and bacillary peliosis hepatitis), as described below. (See <a class="local">'Clinical manifestations'</a> above and <a class="local">'Bacillary angiomatosis'</a> below and <a class="local">'Bacillary peliosis hepatitis'</a> below.) </p><p class="headingAnchor" id="H2041320951"><span class="h3">Bacillary angiomatosis</span><span class="headingEndMark"> — </span>This syndrome occurs in patients with advanced HIV who have CD4 counts less than 100 cells/microL. It is caused by either <em>B. quintana </em>or <em>B. henselae. </em>Affected patients present with vascular lesions that most frequently involve the skin but can affect other organs, such as bone and lymph nodes  (<a class="graphic graphic_picture graphicRef78497" href="/z/d/graphic/78497.html" rel="external">picture 1</a> and <a class="graphic graphic_picture graphicRef82760" href="/z/d/graphic/82760.html" rel="external">picture 2</a>) [<a href="#rid12">12</a>]. Patients with infection due to <em>B. quintana </em>may be more likely to have lytic bone lesions than patients with <em>B. henselae </em>[<a href="#rid11">11</a>]<em>. </em>Further details are found separately. (See  <a class="medical medical_review" href="/z/d/html/5512.html" rel="external">"Bartonella infections in people with HIV", section on 'Bacillary angiomatosis'</a>.)</p><p class="headingAnchor" id="H4290824461"><span class="h3">Bacillary peliosis hepatitis</span><span class="headingEndMark"> — </span>Like bacillary angiomatosis, this syndrome occurs in patients with advanced HIV-related immunosuppression (CD4 &lt;100 cells/microL). Patients with this syndrome present with abdominal pain and hepatosplenomegaly, with or without systemic symptoms (eg, fever); laboratory tests reveal elevated alkaline phosphatase. Data suggest that <em>B. quintana </em>is less likely to cause this syndrome than <em>B. henselae </em>[<a href="#rid11">11,41</a>]<em>. </em>Detailed discussion is found separately. (See  <a class="medical medical_review" href="/z/d/html/5512.html" rel="external">"Bartonella infections in people with HIV", section on 'Bacillary peliosis hepatis and splenitis'</a>.)</p><p class="headingAnchor" id="H7"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H519515092"><span class="h2">When to suspect B. quintana infection</span><span class="headingEndMark"> — </span>In general, <em>B. quintana</em> infection should be suspected in patients with an unexplained systemic febrile illness or culture-negative endocarditis, especially if the person is experiencing homelessness or living in crowded living conditions where lice infestations can occur. (See <a class="local">'Clinical manifestations'</a> above.)</p><p>Among patients with advanced HIV (eg, CD4 &lt;100 cells/microL), symptoms and signs of bacillary angiomatosis (eg, angiomatous vascular cutaneous lesions, lytic bone lesion) or bacillary peliosis hepatis (eg, abdominal pain, hepatosplenomegaly, elevated alkaline phosphatase, hypodense liver lesions on imaging) should increase suspicion for either <em>B. quintana </em>or <em>B. henselae </em>infection. (See <a class="local">'Bacillary angiomatosis'</a> above and <a class="local">'Bacillary peliosis hepatitis'</a> above and  <a class="medical medical_review" href="/z/d/html/5512.html" rel="external">"Bartonella infections in people with HIV"</a>.)</p><p class="headingAnchor" id="H126975918"><span class="h2">Confirming the diagnosis</span><span class="headingEndMark"> — </span>The diagnosis of <em>B</em>. <em>quintana</em> infection is challenging. A definitive diagnosis of <em>Bartonella</em> infection is made by identifying the organism from culture or polymerase chain reaction (PCR) of blood or tissue. However, because culturing <em>Bartonella</em> is difficult, the diagnosis is often made based on positive serologic antibody tests (IgM or IgG); such serologic tests provide supportive, but not definitive, evidence of infection.</p><p>When an infection due to <em>B. quintana </em>is suspected, we send blood samples for the following tests: </p><p class="bulletIndent1"><span class="glyph">●</span>Two sets of blood cultures. We ask the microbiology lab to incubate the cultures for at least 28 days. In a case series of 14 infected individuals in the United States, the average time to culture positivity was 12 days [<a href="#rid25">25</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>Bartonella<em> </em>serology (ie, IgM and IgG antibodies).</p><p class="bulletIndent1"><span class="glyph">●</span>Bartonella PCR testing, if available.</p><p></p><p>Because at least 5 percent of the general population has positive IgG titers to <em>Bartonella</em>, a positive test should be interpreted in the context of the patient's epidemiologic and clinical features. Furthermore, antibody production in response to <em>B. quintana</em> infection appears to vary. As an example, patients with acute febrile illness or endocarditis typically develop high-level antibody titers, whereas those with chronic <em>B. quintana</em> bacteremia often have lower-level antibody response [<a href="#rid6">6,7</a>]. Once individuals recover from chronic infection, low-level detectable titers usually persist.</p><p>Histopathology does not typically play a role in the diagnosis of <em>B. quintana</em> infections, except in persons with HIV who have cutaneous bacillary angiomatosis or in persons with endocarditis who have undergone valve replacement surgery. If a tissue sample is obtained, we ask the laboratory to perform <em>Bartonella</em> cultures and PCR on the tissue. Bartonella organism can also be identified in a Warthin-Starry tissue stain, but this process is very time consuming and may not be available at some laboratories. </p><p>Extensive discussion of the microbiologic diagnosis of bartonella infections is found separately. (See  <a class="medical medical_review" href="/z/d/html/16504.html" rel="external">"Microbiologic diagnosis of Bartonella infections"</a>.)</p><p class="headingAnchor" id="H539172052"><span class="h2">Additional evaluation</span></p><p class="headingAnchor" id="H3954801685"><span class="h3">Evaluate for endocarditis</span><span class="headingEndMark"> — </span>Patients with a <em>B. quintana</em> febrile illness or bacteremia should undergo careful evaluation for endocarditis, including echocardiography, since endocarditis is treated differently and can have serious complications. Diagnosis and echocardiography of bartonella endocarditis is discussed in detail separately (See  <a class="medical medical_review" href="/z/d/html/2145.html" rel="external">"Endocarditis caused by Bartonella"</a>.) </p><p class="headingAnchor" id="H1495927093"><span class="h3">Evaluate for underlying predisposing conditions</span><span class="headingEndMark"> — </span>Patients diagnosed with infections due to <em>B. quintana</em> should undergo thorough evaluation to identify underlying risk factors. </p><p class="bulletIndent1"><span class="glyph">●</span>Physical examination for evidence of lice infestation (eg, pruritus, visualization of live lice or nits) or poor hygiene </p><p class="bulletIndent1"><span class="glyph">●</span>Clinical history for suggestion of substance use disorder (eg, alcohol, injection drug use), housing situation, and risk factors for HIV.</p><p class="bulletIndent1"><span class="glyph">●</span>HIV testing. (See  <a class="medical medical_review" href="/z/d/html/3736.html" rel="external">"Screening and diagnostic testing for HIV infection"</a>.)</p><p></p><p class="headingAnchor" id="H589588154"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis for <em>B. quintana </em>infections depends on the clinical syndrome.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Febrile illness</strong> – The differential for febrile illnesses is very broad but can be narrowed in patients with recurrent periodic fevers living in crowded conditions where lice infestations can occur. Examples include the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Louse-borne relapsing fever</strong> – This syndrome, which primarily occurs in Africa, is acquired from lice and is caused by <em>Borrelia recurrentis</em>. Patients have recurrent fevers with three- to six-day intervals between episodes. The diagnosis is usually made by identifying the organism in thin and thick smears of blood. (See  <a class="medical medical_review" href="/z/d/html/7898.html" rel="external">"Microbiology, pathogenesis, and epidemiology of relapsing fever"</a> and  <a class="medical medical_review" href="/z/d/html/7897.html" rel="external">"Clinical features, diagnosis, and management of relapsing fever"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Tick-borne relapsing fever</strong> – This illness is caused by infection with a spirochete (<em>Borrelia</em> species) and the organism is transmitted by the soft tick Ornithodorus. In the United States, this disorder predominantly occurs in western states. The clinical illness and diagnosis are similar to louse-borne relapsing fever. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Epidemic typhus</strong> – This infection is acquired from lice and is caused by <em>Rickettsia prowazekii. </em>It is primarily reported in Africa and the rural highlands of South America and Asia. The diagnosis is made by serologic antibody tests. (See  <a class="medical medical_review" href="/z/d/html/7905.html" rel="external">"Epidemic typhus"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Tuberculosis</strong> – Infection with <em>M. tuberculosis</em> is often associated with prolonged periods of intermittent fevers, usually with cough and abnormal chest imaging. (See  <a class="medical medical_review" href="/z/d/html/7026.html" rel="external">"Pulmonary tuberculosis: Clinical manifestations and complications"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Malaria</strong> – Patients with malaria typically have intermittent daily fevers, but later stage illness is characterized by periodic fevers every one to three days. The diagnosis is made by visualizing the organism on thin and thick blood smears or by positive antigen tests. (See  <a class="medical medical_review" href="/z/d/html/5709.html" rel="external">"Malaria: Clinical manifestations and diagnosis in nonpregnant adults and children"</a>.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Typhoid and paratyphoid fever (ie, enteric fever)</strong> – This infection is caused by specific strains of <em>Salmonella</em>, spreads by fecal-oral route, and occurs primarily in Africa and south Asia in crowded areas with poor sanitation. The diagnosis is made by positive stool or blood cultures. (See  <a class="medical medical_review" href="/z/d/html/2708.html" rel="external">"Enteric (typhoid and paratyphoid) fever: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Endocarditis</strong> – Individuals who are homeless who inject drugs are at particular risk for bacterial and fungal endocarditis, particularly staphylococcal endocarditis, which may present subacutely. Blood cultures are generally positive if patients have not received prior antibiotic therapy. (See  <a class="medical medical_review" href="/z/d/html/2143.html" rel="external">"Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Endemic fungal infections</strong> – Infections, such as histoplasmosis and coccidioidomycosis, can present with recurrent febrile syndromes. Endemic fungal infections are typically diagnosed with serology, antigen testing, or biopsy. (See  <a class="medical medical_review" href="/z/d/html/2461.html" rel="external">"Diagnosis and treatment of disseminated histoplasmosis in patients without HIV", section on 'Diagnosis of disseminated histoplasmosis'</a> and  <a class="medical medical_review" href="/z/d/html/2420.html" rel="external">"Coccidioidomycosis: Laboratory diagnosis and screening", section on 'Diagnostic tests'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Nontuberculous mycobacterial infections</strong> – These infections can cause chronic fever, malaise, and weight loss. In patients with advanced HIV, disseminated <em>M. avium </em>complex is not uncommon, and the diagnosis is made by culturing the organism from blood. (See  <a class="medical medical_review" href="/z/d/html/3755.html" rel="external">"Mycobacterium avium complex (MAC) infections in persons with HIV"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Malignancy</strong> – Many malignancies can cause recurrent fever (eg, lymphoma, renal cell carcinoma, acute lymphoblastic leukemia). The Pel-Ebstein fever associated with Hodgkin's lymphoma is characterized by fevers that cyclically increase then decrease over one to two weeks. (See  <a class="medical medical_review" href="/z/d/html/4688.html" rel="external">"Clinical presentation and diagnosis of classic Hodgkin lymphoma in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bacillary angiomatosis and bacillary peliosis hepatitis</strong> – The differential diagnosis for these syndromes is found separately. (See  <a class="medical medical_review" href="/z/d/html/5512.html" rel="external">"Bartonella infections in people with HIV", section on 'Bacillary angiomatosis'</a> and  <a class="medical medical_review" href="/z/d/html/5512.html" rel="external">"Bartonella infections in people with HIV", section on 'Bacillary peliosis hepatis and splenitis'</a>.)</p><p></p><p class="headingAnchor" id="H12"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>Management of <em>B. quintana </em>infections consists of antibiotic therapy and treatment of underlying predisposing conditions. </p><p class="headingAnchor" id="H4229623589"><span class="h2">Antibiotic selection</span><span class="headingEndMark"> — </span>Data regarding antibiotic selection for <em>B. quintana </em>infections are scarce; there are no randomized trials directly comparing antibiotic regimens.</p><p class="headingAnchor" id="H2949954983"><span class="h3">Febrile illness or bacteremia</span><span class="headingEndMark"> — </span>For patients with either of these syndromes in whom endocarditis has been ruled out, we suggest combination therapy with <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> and <a class="drug drug_general" data-topicid="9864" href="/z/d/drug information/9864.html" rel="external">rifampin</a>. </p><p class="headingAnchor" id="H2808339001"><span class="h4">Preferred regimen</span></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">Doxycycline</a> (100 mg orally every 12 hours) for 28 days, <strong>PLUS</strong> </p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9864" href="/z/d/drug information/9864.html" rel="external">Rifampin</a> (300 mg orally every 12 hours) for 14 days.</p><p></p><p class="bulletIndent1"><a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">Doxycycline</a> is the key component of therapy for serious bartonella infections [<a href="#rid42">42</a>]. For patients who cannot take oral therapy, intravenous formulations can be used.</p><p></p><p class="bulletIndent1">Combination therapy versus monotherapy for treatment of febrile illness or bacteremia without endocarditis has not been evaluated in studies. However, for patients with bartonella endocarditis, retrospective data suggest that combining <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> with at least 14 days of <a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">gentamicin</a> increases the likelihood of recovery compared with monotherapy with doxycycline [<a href="#rid43">43</a>]. We favor <a class="drug drug_general" data-topicid="9864" href="/z/d/drug information/9864.html" rel="external">rifampin</a> (despite its lack of clinical data) as the second agent because of gentamicin's increased risk of nephrotoxicity [<a href="#rid42">42</a>]. Both rifampin and gentamicin provide intracellular activity against the organism. </p><p></p><p class="bulletIndent1">Treatment of asymptomatic patients with <em>B. quintana </em>bacteremia has been found to eradicate infection. In a randomized trial of 20 individuals experiencing homelessness in France who had positive screening blood cultures, treatment with <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> and gentamycin was significantly associated with clearance of bacteremia compared with no treatment [<a href="#rid44">44</a>]. Among those who completed the protocol, eradication of <em>B. quintana</em> occurred in all seven treated patients compared with two of nine untreated patients. </p><p></p><p class="headingAnchor" id="H2430457665"><span class="h4">Alternative therapy</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Replacement for </strong><a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> – If doxycycline is not an option, we use combination therapy with <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">azithromycin</a> (500 mg orally or intravenously once daily) for 28 days and <a class="drug drug_general" data-topicid="9864" href="/z/d/drug information/9864.html" rel="external">rifampin</a> for 14 days, as dosed above.</p><p></p><p class="bulletIndent1">Clinical data supporting <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">azithromycin</a> are limited, but <a class="drug drug_general" data-topicid="9418" href="/z/d/drug information/9418.html" rel="external">erythromycin</a> has been used effectively for treatment of bartonella infections in patients with HIV [<a href="#rid45">45,46</a>]; we favor azithromycin due to patients' frequent intolerance of erythromycin.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Replacement for </strong><a class="drug drug_general" data-topicid="9864" href="/z/d/drug information/9864.html" rel="external">rifampin</a> – For patients who cannot take rifampin, we combine <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> with <a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">gentamicin</a> (3 mg/kg/day intravenously once daily, adjusted to achieve trough serum concentrations of &lt;1 mcg/mL, for 14 days).</p><p></p><p class="bulletIndent1"><a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">Gentamicin</a> has been commonly used as a second agent for treatment of serious bartonella infections [<a href="#rid42">42</a>]. Renal function should be monitored for patients taking gentamicin.</p><p></p><p><a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">Trimethoprim-sulfamethoxazole</a>, fluoroquinolones, penicillins, and first-generation cephalosporins probably do not have reliable activity against <em>B</em>. <em>quintana</em> and are not recommended.</p><p class="headingAnchor" id="H3284051966"><span class="h3">Endocarditis</span><span class="headingEndMark"> — </span>Patients with endocarditis require a longer duration of antibiotics, closer monitoring, and long-term follow-up. Specific treatment recommendations for bartonella endocarditis are found separately. (See  <a class="medical medical_review" href="/z/d/html/2145.html" rel="external">"Endocarditis caused by Bartonella"</a>.)</p><p class="headingAnchor" id="H2428759871"><span class="h3">Bacillary angiomatosis and peliosis hepatitis</span><span class="headingEndMark"> — </span>Treatment of these syndromes is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5512.html" rel="external">"Bartonella infections in people with HIV", section on 'Bacillary angiomatosis'</a> and  <a class="medical medical_review" href="/z/d/html/5512.html" rel="external">"Bartonella infections in people with HIV", section on 'Bacillary peliosis hepatis and splenitis'</a>.)</p><p class="headingAnchor" id="H2101829433"><span class="h2">Adjunctive therapies</span><span class="headingEndMark"> — </span>In addition to treatment with antibiotics, management of predisposing underlying conditions should be addressed, if possible.</p><p>Lice infestation is typically treated with topical therapies but sometimes requires oral antimicrobial therapy. Household contacts should be examined for evidence of lice infection, and household cleaning recommendations should be provided. More information regarding management of lice is found separately. (See  <a class="medical medical_review" href="/z/d/html/4035.html" rel="external">"Pediculosis capitis", section on 'Treatment'</a> and  <a class="medical medical_review" href="/z/d/html/4036.html" rel="external">"Pediculosis corporis", section on 'Management'</a> and  <a class="medical medical_review" href="/z/d/html/4037.html" rel="external">"Pediculosis pubis and pediculosis ciliaris", section on 'Management'</a>.)</p><p>Other predisposing conditions should be treated as well, including HIV and substance use disorder. (See  <a class="medical medical_review" href="/z/d/html/3773.html" rel="external">"Selecting antiretroviral regimens for treatment-naïve persons with HIV-1: General approach"</a> and  <a class="medical medical_review" href="/z/d/html/108891.html" rel="external">"Alcohol use disorder: Treatment overview"</a> and  <a class="medical medical_review" href="/z/d/html/16753.html" rel="external">"Substance use disorders: Psychosocial management"</a>.)</p><p>Education regarding personal hygiene and social interventions to address housing instability are also helpful, if applicable.</p><p class="headingAnchor" id="H1287234613"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>With the exception of endocarditis, death rarely occurs in either the acute or chronic forms of illness [<a href="#rid2">2,36</a>]. During the World War I outbreaks of trench fever, no deaths were reported even though there were no antimicrobial treatments available at that time [<a href="#rid42">42</a>]. Limited data suggest that patients with <em>B. quintana </em>endocarditis have higher attributable mortality rates than other causes of endocarditis; in a retrospective review of 38 patients with confirmed <em>B. quintana </em>endocarditis, three patients (8 percent) died as a consequence of their infection [<a href="#rid47">47</a>].</p><p class="headingAnchor" id="H3613452945"><span class="h1">INFECTION PREVENTION</span><span class="headingEndMark"> — </span>Treatment of underlying predisposing conditions in infected patients and evaluation of household members helps to prevent recurrences in individual patients, as discussed above. (See <a class="local">'Adjunctive therapies'</a> above.)</p><p>In health care settings, standard precautions suffice for patient management, unless the patient has lice. Providers should follow their hospital policies for management of hospitalized patients with lice; we use contact precautions for our hospitalized patients with lice.</p><p>For patients with <em>B. quintana </em>infection and lice who live in congregated living facilities or are homeless, reporting the infection to public health authorities allows identification of outbreak settings.</p><p class="headingAnchor" id="H234332289"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Geography</strong> – <em>B. quintana </em>has a worldwide distribution, although clinically significant infections are uncommon globally. (See <a class="local">'Geography'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vector of transmission</strong> – The primary route of spread is via exposure to infected lice. (See <a class="local">'Transmission'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> – Infestation with lice is a major risk factor. As such, crowded household environments with poor hygienic conditions are associated with infection. HIV, alcohol use disorder, and injection drug use may be additional risk factors. (See <a class="local">'Risk factors'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – Several syndromes can be caused by <em>B. quintana. </em></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Febrile illness</strong> – This form of infection is characterized by fever and malaise that may be self-limited or cause chronic infection. Classic trench fever findings include bone pain in the shins and periodic fevers every four to five days that last four to five days before resolving after several weeks. Other nonspecific fever patterns are more common in contemporary illness. (See <a class="local">'Febrile illness'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Chronic bacteremia</strong> – After resolution of febrile events, prolonged asymptomatic bacteremia can persist for weeks to months. (See <a class="local">'Chronic bacteremia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Endocarditis</strong> – Data suggest that 20 to 43 percent of patients with <em>B. quintana </em>bacteremia have endocarditis. The organism is also a significant cause of culture-negative endocarditis. (See <a class="local">'Endocarditis'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Bacillary angiomatosis and bacillary peliosis hepatis</strong> – These syndromes occur in patients with advanced HIV (CD4 counts &lt;100 cells/microL). Patients with bacillary angiomatosis present with vascular lesions usually involving the skin. Peliosis hepatis presents with abdominal pain, hepatosplenomegaly, and elevated alkaline phosphatase. (See <a class="local">'Bacillary angiomatosis'</a> above and <a class="local">'Bacillary peliosis hepatitis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – A definitive diagnosis of <em>Bartonella</em> infection is made by identifying the organism from culture or polymerase chain reaction (PCR) of blood or tissue. However, because culturing <em>Bartonella</em> is difficult, the diagnosis is often made based on positive serologic antibody tests (IgM or IgG) which provide supportive, but not definitive, evidence of infection. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Additional evaluation</strong> – Patients with a <em>B. quintana</em> febrile illness or bacteremia should undergo careful evaluation for endocarditis, including echocardiography. (See <a class="local">'Evaluate for endocarditis'</a> above.)</p><p></p><p class="bulletIndent1">Physical examination and history should seek evidence of lice, and HIV testing should be performed. (See <a class="local">'Evaluate for underlying predisposing conditions'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antibiotic selection</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Febrile illness or bacteremia</strong> – For patients with either of these conditions, we suggest combination therapy with <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> (100 mg orally or intravenously every 12 hours) for 28 days, PLUS <a class="drug drug_general" data-topicid="9864" href="/z/d/drug information/9864.html" rel="external">rifampin</a> (300 mg orally or intravenously every 12 hours) for 14 days (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Antibiotic selection'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Endocarditis, bacillary angiomatosis, and bacillary peliosis hepatis</strong> – Antibiotic selection for these conditions is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/2145.html" rel="external">"Endocarditis caused by Bartonella", section on 'Antimicrobial therapy'</a> and  <a class="medical medical_review" href="/z/d/html/2145.html" rel="external">"Endocarditis caused by Bartonella", section on 'Surgery'</a> and  <a class="medical medical_review" href="/z/d/html/5512.html" rel="external">"Bartonella infections in people with HIV", section on 'Specific syndromes'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Adjunctive therapy</strong> – Lice should be treated with topical or oral agents, as discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4036.html" rel="external">"Pediculosis corporis", section on 'Management'</a> and  <a class="medical medical_review" href="/z/d/html/4035.html" rel="external">"Pediculosis capitis", section on 'Treatment'</a>.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Foucault C, Brouqui P, Raoult D. Bartonella quintana characteristics and clinical management. Emerg Infect Dis 2006; 12:217.</a></li><li><a class="nounderline abstract_t">Relman DA. Has trench fever returned? N Engl J Med 1995; 332:463.</a></li><li><a class="nounderline abstract_t">Anstead GM. The centenary of the discovery of trench fever, an emerging infectious disease of World War 1. Lancet Infect Dis 2016; 16:e164.</a></li><li><a class="nounderline abstract_t">Vinson JW. In vitro cultivation of the rickettsial agent of trench fever. Bull World Health Organ 1966; 35:155.</a></li><li><a class="nounderline abstract_t">Spach DH, Kanter AS, Dougherty MJ, et al. Bartonella (Rochalimaea) quintana bacteremia in inner-city patients with chronic alcoholism. N Engl J Med 1995; 332:424.</a></li><li><a class="nounderline abstract_t">Brouqui P, Lascola B, Roux V, Raoult D. Chronic Bartonella quintana bacteremia in homeless patients. N Engl J Med 1999; 340:184.</a></li><li><a class="nounderline abstract_t">Drancourt M, Mainardi JL, Brouqui P, et al. Bartonella (Rochalimaea) quintana endocarditis in three homeless men. N Engl J Med 1995; 332:419.</a></li><li><a class="nounderline abstract_t">Raoult D, Fournier PE, Drancourt M, et al. Diagnosis of 22 new cases of Bartonella endocarditis. Ann Intern Med 1996; 125:646.</a></li><li><a class="nounderline abstract_t">Spach DH, Kanter AS, Daniels NA, et al. Bartonella (Rochalimaea) species as a cause of apparent "culture-negative" endocarditis. Clin Infect Dis 1995; 20:1044.</a></li><li><a class="nounderline abstract_t">Tasher D, Raucher-Sternfeld A, Tamir A, et al. Bartonella quintana, an Unrecognized Cause of Infective Endocarditis in Children in Ethiopia. Emerg Infect Dis 2017; 23.</a></li><li><a class="nounderline abstract_t">Koehler JE, Sanchez MA, Garrido CS, et al. Molecular epidemiology of bartonella infections in patients with bacillary angiomatosis-peliosis. N Engl J Med 1997; 337:1876.</a></li><li><a class="nounderline abstract_t">Relman DA, Loutit JS, Schmidt TM, et al. The agent of bacillary angiomatosis. An approach to the identification of uncultured pathogens. N Engl J Med 1990; 323:1573.</a></li><li><a class="nounderline abstract_t">Faccini-Martínez ÁA, Kmetiuk LB, Blanton LS, et al. Bartonella spp. and Typhus Group Rickettsiae among Persons Experiencing Homelessness, São Paulo, Brazil. Emerg Infect Dis 2023; 29:418.</a></li><li><a class="nounderline abstract_t">McCormick DW, Rowan SE, Pappert R, et al. Bartonella Seroreactivity Among Persons Experiencing Homelessness During an Outbreak of Bartonella quintana in Denver, Colorado, 2020. Open Forum Infect Dis 2021; 8:ofab230.</a></li><li><a class="nounderline abstract_t">Jackson LA, Spach DH, Kippen DA, et al. Seroprevalence to Bartonella quintana among patients at a community clinic in downtown Seattle. J Infect Dis 1996; 173:1023.</a></li><li><a class="nounderline abstract_t">Brouqui P, Houpikian P, Dupont HT, et al. Survey of the seroprevalence of Bartonella quintana in homeless people. Clin Infect Dis 1996; 23:756.</a></li><li><a class="nounderline abstract_t">Guibal F, de La Salmonière P, Rybojad M, et al. High seroprevalence to Bartonella quintana in homeless patients with cutaneous parasitic infestations in downtown Paris. J Am Acad Dermatol 2001; 44:219.</a></li><li><a class="nounderline abstract_t">Brouqui P, Stein A, Dupont HT, et al. Ectoparasitism and vector-borne diseases in 930 homeless people from Marseilles. Medicine (Baltimore) 2005; 84:61.</a></li><li><a class="nounderline abstract_t">Comer JA, Flynn C, Regnery RL, et al. Antibodies to Bartonella species in inner-city intravenous drug users in Baltimore, Md. Arch Intern Med 1996; 156:2491.</a></li><li><a class="nounderline abstract_t">Rydkina EB, Roux V, Gagua EM, et al. Bartonella quintana in body lice collected from homeless persons in Russia. Emerg Infect Dis 1999; 5:176.</a></li><li><a class="nounderline abstract_t">Raoult D, Ndihokubwayo JB, Tissot-Dupont H, et al. Outbreak of epidemic typhus associated with trench fever in Burundi. Lancet 1998; 352:353.</a></li><li><a class="nounderline abstract_t">Bonilla DL, Kabeya H, Henn J, et al. Bartonella quintana in body lice and head lice from homeless persons, San Francisco, California, USA. Emerg Infect Dis 2009; 15:912.</a></li><li><a class="nounderline abstract_t">La Scola B, Fournier PE, Brouqui P, Raoult D. Detection and culture of Bartonella quintana, Serratia marcescens, and Acinetobacter spp. from decontaminated human body lice. J Clin Microbiol 2001; 39:1707.</a></li><li><a class="nounderline abstract_t">Seki N, Kasai S, Saito N, et al. Quantitative analysis of proliferation and excretion of Bartonella quintana in body lice, Pediculus humanus L. Am J Trop Med Hyg 2007; 77:562.</a></li><li><a class="nounderline abstract_t">Shepard Z, Vargas Barahona L, Montalbano G, et al. Bartonella quintana Infection in People Experiencing Homelessness in the Denver Metropolitan Area. J Infect Dis 2022; 226:S315.</a></li><li><a class="nounderline abstract_t">Mai BH. Seroprevalence of Bartonella quintana Infection: A Systematic Review. J Glob Infect Dis 2022; 14:50.</a></li><li><a class="nounderline abstract_t">Rolain JM, Foucault C, Guieu R, et al. Bartonella quintana in human erythrocytes. Lancet 2002; 360:226.</a></li><li><a class="nounderline abstract_t">ITO S, VINSON JW. FINE STRUCTURE OF RICKETTSIA QUINTANA CULTIVATED IN VITRO AND IN THE LOUSE. J Bacteriol 1965; 89:481.</a></li><li><a class="nounderline abstract_t">Raoult D, Drancourt M, Carta A, Gastaut JA. Bartonella (Rochalimaea) quintana isolation in patient with chronic adenopathy, lymphopenia, and a cat. Lancet 1994; 343:977.</a></li><li><a class="nounderline abstract_t">Chomel BB, Kasten RW, Stuckey MJ, et al. Experimental infection of cats with Afipia felis and various Bartonella species or subspecies. Vet Microbiol 2014; 172:505.</a></li><li><a class="nounderline abstract_t">Kernif T, Leulmi H, Socolovschi C, et al. Acquisition and excretion of Bartonella quintana by the cat flea, Ctenocephalides felis felis. Mol Ecol 2014; 23:1204.</a></li><li><a class="nounderline abstract_t">Raoult D, Roux V. The body louse as a vector of reemerging human diseases. Clin Infect Dis 1999; 29:888.</a></li><li><a class="nounderline abstract_t">Leulmi H, Bitam I, Berenger JM, et al. Competence of Cimex lectularius Bed Bugs for the Transmission of Bartonella quintana, the Agent of Trench Fever. PLoS Negl Trop Dis 2015; 9:e0003789.</a></li><li><a class="nounderline abstract_t">Li H, Bai JY, Wang LY, et al. Genetic diversity of Bartonella quintana in macaques suggests zoonotic origin of trench fever. Mol Ecol 2013; 22:2118.</a></li><li><a class="nounderline abstract_t">Ohl ME, Spach DH. Bartonella quintana and urban trench fever. Clin Infect Dis 2000; 31:131.</a></li><li><a class="nounderline abstract_t">Vinson JW, Varela G, Molina-Pasquel C. Trench fever. 3. Induction of clinical disease in volunteers inoculated with Rickettsia quintana propagated on blood agar. Am J Trop Med Hyg 1969; 18:713.</a></li><li><a class="nounderline abstract_t">Drancourt M, Moal V, Brunet P, et al. Bartonella (Rochalimaea) quintana infection in a seronegative hemodialyzed patient. J Clin Microbiol 1996; 34:1158.</a></li><li><a class="nounderline abstract_t">McCormick DW, Rassoulian-Barrett SL, Hoogestraat DR, et al. Bartonella spp. Infections Identified by Molecular Methods, United States. Emerg Infect Dis 2023; 29:467.</a></li><li><a class="nounderline abstract_t">Boodman C, Wuerz T, Lagacé-Wiens P, et al. Serologic testing for Bartonella in Manitoba, Canada, 2010-2020: a retrospective case series. CMAJ Open 2022; 10:E476.</a></li><li><a class="nounderline abstract_t">Koehler JE, Quinn FD, Berger TG, et al. Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis. N Engl J Med 1992; 327:1625.</a></li><li><a class="nounderline abstract_t">Fulchini R, Bloemberg G, Boggian K. Bacillary Angiomatosis and Bacteremia due to Bartonella quintana in a Patient with Chronic Lymphocytic Leukemia. Case Rep Infect Dis 2013; 2013:694765.</a></li><li><a class="nounderline abstract_t">Rolain JM, Brouqui P, Koehler JE, et al. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother 2004; 48:1921.</a></li><li><a class="nounderline abstract_t">Raoult D, Fournier PE, Vandenesch F, et al. Outcome and treatment of Bartonella endocarditis. Arch Intern Med 2003; 163:226.</a></li><li><a class="nounderline abstract_t">Foucault C, Raoult D, Brouqui P. Randomized open trial of gentamicin and doxycycline for eradication of Bartonella quintana from blood in patients with chronic bacteremia. Antimicrob Agents Chemother 2003; 47:2204.</a></li><li><a class="nounderline abstract_t">Tappero JW, Koehler JE, Berger TG, et al. Bacillary angiomatosis and bacillary splenitis in immunocompetent adults. Ann Intern Med 1993; 118:363.</a></li><li><a class="nounderline abstract_t">Koehler JE, Tappero JW. Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus. Clin Infect Dis 1993; 17:612.</a></li><li><a class="nounderline abstract_t">Fournier PE, Lelievre H, Eykyn SJ, et al. Epidemiologic and clinical characteristics of Bartonella quintana and Bartonella henselae endocarditis: a study of 48 patients. Medicine (Baltimore) 2001; 80:245.</a></li></ol></div><div id="topicVersionRevision">Topic 5517 Version 21.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16494745" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Bartonella quintana characteristics and clinical management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7529896" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Has trench fever returned?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27375211" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The centenary of the discovery of trench fever, an emerging infectious disease of World War 1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5297000" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : In vitro cultivation of the rickettsial agent of trench fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7529895" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Bartonella (Rochalimaea) quintana bacteremia in inner-city patients with chronic alcoholism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9895398" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Chronic Bartonella quintana bacteremia in homeless patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7529894" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Bartonella (Rochalimaea) quintana endocarditis in three homeless men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8849149" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Diagnosis of 22 new cases of Bartonella endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7795048" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Bartonella (Rochalimaea) species as a cause of apparent "culture-negative" endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28730981" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Bartonella quintana, an Unrecognized Cause of Infective Endocarditis in Children in Ethiopia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9407154" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Molecular epidemiology of bartonella infections in patients with bacillary angiomatosis-peliosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2233945" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : The agent of bacillary angiomatosis. An approach to the identification of uncultured pathogens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36692454" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Bartonella spp. and Typhus Group Rickettsiae among Persons Experiencing Homelessness, São Paulo, Brazil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34239947" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Bartonella Seroreactivity Among Persons Experiencing Homelessness During an Outbreak of Bartonella quintana in Denver, Colorado, 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8603944" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Seroprevalence to Bartonella quintana among patients at a community clinic in downtown Seattle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8909840" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Survey of the seroprevalence of Bartonella quintana in homeless people.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11174378" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : High seroprevalence to Bartonella quintana in homeless patients with cutaneous parasitic infestations in downtown Paris.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15643300" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Ectoparasitism and vector-borne diseases in 930 homeless people from Marseilles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8944742" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Antibodies to Bartonella species in inner-city intravenous drug users in Baltimore, Md.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10081691" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Bartonella quintana in body lice collected from homeless persons in Russia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9717922" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Outbreak of epidemic typhus associated with trench fever in Burundi.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19523290" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Bartonella quintana in body lice and head lice from homeless persons, San Francisco, California, USA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11325978" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Detection and culture of Bartonella quintana, Serratia marcescens, and Acinetobacter spp. from decontaminated human body lice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17827380" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Quantitative analysis of proliferation and excretion of Bartonella quintana in body lice, Pediculus humanus L.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35749315" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Bartonella quintana Infection in People Experiencing Homelessness in the Denver Metropolitan Area.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35910824" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Seroprevalence of Bartonella quintana Infection: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12133660" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Bartonella quintana in human erythrocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14255718" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : FINE STRUCTURE OF RICKETTSIA QUINTANA CULTIVATED IN VITRO AND IN THE LOUSE.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7909030" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Bartonella (Rochalimaea) quintana isolation in patient with chronic adenopathy, lymphopenia, and a cat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24972870" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Experimental infection of cats with Afipia felis and various Bartonella species or subspecies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24400877" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Acquisition and excretion of Bartonella quintana by the cat flea, Ctenocephalides felis felis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10589908" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The body louse as a vector of reemerging human diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26000974" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Competence of Cimex lectularius Bed Bugs for the Transmission of Bartonella quintana, the Agent of Trench Fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23517327" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Genetic diversity of Bartonella quintana in macaques suggests zoonotic origin of trench fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10913410" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Bartonella quintana and urban trench fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5810799" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Trench fever. 3. Induction of clinical disease in volunteers inoculated with Rickettsia quintana propagated on blood agar.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8727894" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Bartonella (Rochalimaea) quintana infection in a seronegative hemodialyzed patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36823096" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Bartonella spp. Infections Identified by Molecular Methods, United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35640989" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Serologic testing for Bartonella in Manitoba, Canada, 2010-2020: a retrospective case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1435899" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23710386" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Bacillary Angiomatosis and Bacteremia due to Bartonella quintana in a Patient with Chronic Lymphocytic Leukemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15155180" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Recommendations for treatment of human infections caused by Bartonella species.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12546614" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Outcome and treatment of Bartonella endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12821469" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Randomized open trial of gentamicin and doxycycline for eradication of Bartonella quintana from blood in patients with chronic bacteremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8430982" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Bacillary angiomatosis and bacillary splenitis in immunocompetent adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8268340" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11470985" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Epidemiologic and clinical characteristics of Bartonella quintana and Bartonella henselae endocarditis: a study of 48 patients.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
